NEW YORK Martin Shkreli, the pharmaceutical entrepreneur vilified as the "pharma bro" for raising the price of a life-saving drug by 5,000 percent, will go on trial on Monday for what U.S. prosecutors called a Ponzi-like scheme at his former hedge fund and a drug company he once ran.
- Pharmacy executive tied to 2012 U.S. meningitis outbreak to be sentenced
- Trump reaches out to lawmakers on healthcare as another says 'no' |
- Seattle Genetics, Takeda lymphoma drug succeeds late-stage trial
- South Africa bans sale of live hens to contain bird flu
- Rubbish piles raise health fears in strike-hit Greece
CHICAGO The U.S. Department of Agriculture has found repeated import violations in raw Brazilian beef, including abscesses and unidentified foreign material, a top agency official said, explaining reasons for a U.S. ban on imports of fresh Brazilian beef.
ZURICH Roche's investigational haemophilia drug emicizumab cut the bleed rate by 87 percent in patients with resistance to standard therapy compared with those who received another treatment, the Swiss company said on Monday.
NEW YORK Health insurers are concerned about the U.S. Senate's plans to cut the Medicaid program for the poor and the impact such a move would have on state governments, the industry's largest lobbyist said on Friday.
ZURICH A European Medicines Agency (EMA) panel recommended on Friday approving Novartis's Kisqali drug, bolstering the Swiss drugmaker's bid to challenge rival Pfizer's Ibrance against tough-to-treat breast cancer.